Prognostic factors in advanced multiple myeloma patients treated with the association of bortezomib, melphalan, prednisone and thalidomide (VMPT)

被引：0
|
作者：
Palumbo, A. [1 ]
Gay, F. [1 ]
Ambrosini, M. T. [1 ]
Benevolo, G. [2 ]
Pregno, F. [2 ]
Pescosta, N.
Callea, V [3 ]
Cangialosi, C. [4 ]
Caravita, T. [5 ]
Morabito, F. [6 ]
Musto, P. [7 ]
Larocca, A. [1 ]
Caltagirone, S. [1 ]
Avonto, I [1 ]
Cavallo, F. [1 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Turin, Az Osp S Giovanni Battista, Div Ematol, Turin, Italy
[2] Azienda Osped San Giovanni Battista, Turin, Italy
[3] Osped Riuniti Bergamo, Div Ematol, Reggio Di Calabria, Italy
[4] Azienda Osped Cervello, Div Ematol Trapianto Midollo Osseo, Palermo, Italy
[5] Univ Roma Tor Vergata, Osped San Eugenio, Cattedra & Div Ematol, Rome, Italy
[6] Azienda Osped Cosenza, UOC Ematol, Cosenza, Italy
[7] UOC Ematol Trapianto Cellule Staminali, CROB, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [21] Oral melphalan, prednisone and thalidomide for multiple myeloma.
    Palumbo, A
    Bringhen, S
    Musto, P
    Caravita, T
    Capozzi, R
    Callea, V
    Cangialosi, C
    Montanaro, M
    Catalano, L
    Grasso, M
    Petti, MC
    Merla, M
    Falchi, L
    Omedè, P
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Gay, F
    Falco, P
    Boccadoro, M
    BLOOD, 2005, 106 (11) : 230A - 230A
  • [22] BORTEZOMIB-MELPHALAN-PREDNISONE-THALIDOMIDE FOLLOWED BY BORTEZOMIB-THALIDOMIDE MAINTENANCE FOR INITIAL THERAPY OF MULTIPLE MYELOMA: A PROSPECTIVE RANDOMIZED TRIAL
    Palumbo, A.
    Bringhen, S.
    Rossi, D.
    Ria, R.
    Offidani, M.
    Musto, P.
    Petrucci, M. T.
    Omede, P.
    Di Raimondo, F.
    Boccadoro, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 350 - 350
  • [23] Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
    Morabito, Fortunato
    Bringhen, Sara
    Larocca, Alessandra
    Wijermans, Pierre
    Victoria Mateos, Maria
    Gimsing, Peter
    Mazzone, Carla
    Gottardi, Daniela
    Omede, Paola
    Zweegman, Sonja
    Jose Lahuerta, Juan
    Zambello, Renato
    Musto, Pellegrino
    Magarotto, Valeria
    Schaafsma, Martijn
    Oriol, Albert
    Juliusson, Gunnar
    Cerrato, Chiara
    Catalano, Lucio
    Gentile, Massimo
    Isabel Turel, Ana
    Liberati, Anna Marina
    Cavalli, Maide
    Rossi, Davide
    Passera, Roberto
    Rosso, Stefano
    Beksac, Meral
    Cavo, Michele
    Waage, Anders
    San Miguel, Jesus
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    Offidani, Massimo
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 355 - 362
  • [24] What is the tolerance of the addition of thalidomide to melphalan-prednisone in patients treated for myeloma?
    Macro, Margaret
    HEMATOLOGIE, 2013, 19 (01): : 16 - 17
  • [25] PROGNOSTIC FACTORS AND SURVIVAL IN MULTIPLE-MYELOMA - ANALYSIS OF 91 CASES TREATED BY MELPHALAN AND PREDNISONE
    GOBBI, M
    CAVO, M
    SAVELLI, G
    BACCARANI, M
    TURA, S
    HAEMATOLOGICA, 1980, 65 (04) : 437 - 445
  • [26] BORTEZOMIB (VELCADE)-MELPHALAN-PREDNISONE (VMP) VERSUS VELCADE-THALIDOMIDE-PREDNISONE (VTP) IN ELDERLY UNTREATED MULTIPLE MYELOMA (MM) PATIENTS
    Mateos, M. V.
    Oriol, A.
    Martinez, J.
    Cibeira, M. T.
    de Paz, R.
    Terol, M. J.
    Garcia-Larana, J.
    Bengoechea, E.
    Martinez, R.
    Martin, A.
    de Arriba, F.
    Palomera, L.
    Hernandez, J. M.
    Bello, J. L.
    Martin, M. L.
    Gonzalez, Y.
    Lahuerta, J. J.
    Blade, J.
    San Miguel, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 190 - 190
  • [27] Subcutaneous Bortezomib, Melphalan and Prednisone in Elderly Newly Diagnosed Multiple Myeloma Patients
    Herbaux, Charles
    Joao, Cristina M.
    Plocque, Alexia
    Richez, Valentine
    Gay, Francesca
    Renaud, Loic
    Legros, Laurence
    Garderet, Laurent
    Ikhlef, Souhila
    Pegourie, Brigitte
    Escoffre-Barbe, Martine
    Royer, Bruno
    Voillat, Laurent
    Hulin, Cyrille
    Banos, Anne
    Voog, Eric G.
    Karlin, Lionel
    Stoppa, Anne-Marie
    Benboubker, Lotfi
    Zweegman, Sonja
    De Jongh, Eva
    Abildgaard, Niels
    Le Du, Katell
    Jurczyszyn, Artur J.
    Moreau, Philippe
    Facon, Thierry
    Caillot, Denis
    Terpos, Evangelos
    Leleu, Xavier
    BLOOD, 2014, 124 (21)
  • [28] Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
    Kapoor, P.
    Rajkumar, S. V.
    Dispenzieri, A.
    Gertz, M. A.
    Lacy, M. Q.
    Dingli, D.
    Mikhael, J. R.
    Roy, V.
    Kyle, R. A.
    Greipp, P. R.
    Kumar, S.
    Mandrekar, S. J.
    LEUKEMIA, 2011, 25 (04) : 689 - 696
  • [29] Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
    P Kapoor
    S V Rajkumar
    A Dispenzieri
    M A Gertz
    M Q Lacy
    D Dingli
    J R Mikhael
    V Roy
    R A Kyle
    P R Greipp
    S Kumar
    S J Mandrekar
    Leukemia, 2011, 25 : 689 - 696
  • [30] Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma
    Palumbo, A
    Avonto, I
    Bruno, B
    Ambrosini, MT
    Bringhen, S
    Cavallo, F
    Falco, P
    Boccadoro, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (04) : 273 - 277
12345